Trial of New Alzheimer’s Drug Reports Disappointing Results
A closely watched clinical trial of a potential Alzheimer’s drug failed to prevent or slow cognitive decline, another disappointment in the long and challenging effort to find solutions for the disease. The decade-long trial was the first time people who were genetically destined to develop the disease — but who did not yet have any…